Biomedical Investments

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Biomedical Investments' primary sector focus?

Biomedical Investments primarily focuses on the Health Tech & Life Sciences sector, with all of its recorded investments and exits concentrated in this area.

Can you name some notable companies in Biomedical Investments' portfolio?

Biomedical Investments' portfolio includes Gamida Cell and XTL Biopharmaceuticals. Gamida Cell has raised $416.22M, and XTL Biopharmaceuticals has raised $30.04M.

What is the investment range for Biomedical Investments?

Biomedical Investments' recorded investment range is between $1.34M and $16M.

Has Biomedical Investments had any exits from its portfolio companies?

Yes, Biomedical Investments had an exit in October 2018 when Gamida Cell went public on NASDAQ with a valuation of $210M, having raised $50M in capital.

When did Biomedical Investments make its first recorded investment?

Biomedical Investments made its first recorded investment in November 2004.

What types of funding stages has Biomedical Investments participated in?

Biomedical Investments has participated in Seed and D Round funding stages.

Has Biomedical Investments acted as a lead investor in any rounds?

According to startupim data, Biomedical Investments has not acted as a lead investor in any of its recorded investment rounds.

What was Biomedical Investments' most recent recorded investment activity?

Biomedical Investments' most recent recorded investment activity was in September 2006.